179 related articles for article (PubMed ID: 19594910)
1. Reactivation from latency displays HIV particle budding at plasma membrane, accompanying CD44 upregulation and recruitment.
Suyama M; Daikoku E; Goto T; Sano K; Morikawa Y
Retrovirology; 2009 Jul; 6():63. PubMed ID: 19594910
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains.
Jolly C; Sattentau QJ
J Virol; 2007 Aug; 81(15):7873-84. PubMed ID: 17522207
[TBL] [Abstract][Full Text] [Related]
3. The intracellular plasma membrane-connected compartment in the assembly of HIV-1 in human macrophages.
Nkwe DO; Pelchen-Matthews A; Burden JJ; Collinson LM; Marsh M
BMC Biol; 2016 Jun; 14():50. PubMed ID: 27338237
[TBL] [Abstract][Full Text] [Related]
4. Basic motifs target PSGL-1, CD43, and CD44 to plasma membrane sites where HIV-1 assembles.
Grover JR; Veatch SL; Ono A
J Virol; 2015 Jan; 89(1):454-67. PubMed ID: 25320329
[TBL] [Abstract][Full Text] [Related]
5. HIV Reactivation in Latently Infected Cells With Virological Synapse-Like Cell Contact.
Okutomi T; Minakawa S; Hirota R; Katagiri K; Morikawa Y
Viruses; 2020 Apr; 12(4):. PubMed ID: 32276457
[TBL] [Abstract][Full Text] [Related]
6. Assembly of infectious HIV-1 in human epithelial and T-lymphoblastic cell lines.
Grigorov B; Arcanger F; Roingeard P; Darlix JL; Muriaux D
J Mol Biol; 2006 Jun; 359(4):848-62. PubMed ID: 16682056
[TBL] [Abstract][Full Text] [Related]
7. Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.
Ono A; Freed EO
J Virol; 2004 Feb; 78(3):1552-63. PubMed ID: 14722309
[TBL] [Abstract][Full Text] [Related]
8. Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane.
Booth AM; Fang Y; Fallon JK; Yang JM; Hildreth JE; Gould SJ
J Cell Biol; 2006 Mar; 172(6):923-35. PubMed ID: 16533950
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 assembly in macrophages.
Benaroch P; Billard E; Gaudin R; Schindler M; Jouve M
Retrovirology; 2010 Apr; 7():29. PubMed ID: 20374631
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 buds predominantly at the plasma membrane of primary human macrophages.
Welsch S; Keppler OT; Habermann A; Allespach I; Krijnse-Locker J; Kräusslich HG
PLoS Pathog; 2007 Mar; 3(3):e36. PubMed ID: 17381240
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional profiling indicates cAMP-driven reversal of HIV latency in monocytes occurs via transcription factor SP-1.
Moar P; Sushmita K; Kateriya S; Tandon R
Virology; 2020 Mar; 542():40-53. PubMed ID: 32056667
[TBL] [Abstract][Full Text] [Related]
12. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells are attracted to latent HIV-1-infected cells and enable virus reactivation via a non-canonical PI3K-NFκB signaling pathway.
Chandra PK; Gerlach SL; Wu C; Khurana N; Swientoniewski LT; Abdel-Mageed AB; Li J; Braun SE; Mondal D
Sci Rep; 2018 Oct; 8(1):14702. PubMed ID: 30279437
[TBL] [Abstract][Full Text] [Related]
14. Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells.
Biswas P; Poli G; Kinter AL; Justement JS; Stanley SK; Maury WJ; Bressler P; Orenstein JM; Fauci AS
J Exp Med; 1992 Sep; 176(3):739-50. PubMed ID: 1512539
[TBL] [Abstract][Full Text] [Related]
15. CD63 is not required for production of infectious human immunodeficiency virus type 1 in human macrophages.
Ruiz-Mateos E; Pelchen-Matthews A; Deneka M; Marsh M
J Virol; 2008 May; 82(10):4751-61. PubMed ID: 18321974
[TBL] [Abstract][Full Text] [Related]
16. The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro.
La Maestra L; Zaninoni A; Marriott JB; Lazzarin A; Dalgleish AG; Barcellini W
Clin Exp Immunol; 2000 Jan; 119(1):123-9. PubMed ID: 10606973
[TBL] [Abstract][Full Text] [Related]
17. Nef and TNFalpha are coplayers that favor HIV-1 replication in monocytic cells and primary macrophages.
Herbein G; Varin A; Larbi A; Fortin C; Mahlknecht U; Fulop T; Aggarwal BB
Curr HIV Res; 2008 Mar; 6(2):117-29. PubMed ID: 18336259
[TBL] [Abstract][Full Text] [Related]
18. Organization and regulation of intracellular plasma membrane-connected HIV-1 assembly compartments in macrophages.
Mlcochova P; Pelchen-Matthews A; Marsh M
BMC Biol; 2013 Aug; 11():89. PubMed ID: 23915020
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms for macrophage-mediated HIV-1 induction.
Devadas K; Hardegen NJ; Wahl LM; Hewlett IK; Clouse KA; Yamada KM; Dhawan S
J Immunol; 2004 Dec; 173(11):6735-44. PubMed ID: 15557166
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis resistance in HIV-1 persistently-infected cells is independent of active viral replication and involves modulation of the apoptotic mitochondrial pathway.
Fernández Larrosa PN; Croci DO; Riva DA; Bibini M; Luzzi R; Saracco M; Mersich SE; Rabinovich GA; Martínez Peralta L
Retrovirology; 2008 Feb; 5():19. PubMed ID: 18261236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]